Annual FCF
-$19.09 M
-$3.68 M-23.87%
31 December 2023
Summary:
XBiotech annual free cash flow is currently -$19.09 million, with the most recent change of -$3.68 million (-23.87%) on 31 December 2023. During the last 3 years, it has risen by +$49.79 million (+72.29%). XBIT annual FCF is now -128.95% below its all-time high of $65.92 million, reached on 31 December 2021.XBIT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.18 M
+$5.82 M+48.49%
30 September 2024
Summary:
XBiotech quarterly free cash flow is currently -$6.18 million, with the most recent change of +$5.82 million (+48.49%) on 30 September 2024. Over the past year, it has dropped by -$4.66 million (-306.78%). XBIT quarterly FCF is now -108.70% below its all-time high of $71.08 million, reached on 30 June 2021.XBIT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$29.19 M
-$4.66 M-19.01%
30 September 2024
Summary:
XBiotech TTM free cash flow is currently -$29.19 million, with the most recent change of -$4.66 million (-19.01%) on 30 September 2024. Over the past year, it has dropped by -$10.36 million (-54.98%). XBIT TTM FCF is now -138.19% below its all-time high of $76.44 million, reached on 30 June 2021.XBIT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -23.9% | -306.8% | -55.0% |
3 y3 years | +72.3% | -50.7% | -144.5% |
5 y5 years | -14.6% | -20.2% | -47.1% |
XBIT Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -128.9% | +72.3% | -354.6% | +48.5% | -144.3% | at low |
5 y | 5 years | -128.9% | +72.3% | -108.7% | +89.9% | -138.2% | +64.4% |
alltime | all time | -128.9% | +72.3% | -108.7% | +89.9% | -138.2% | +64.4% |
XBiotech Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$6.18 M(-48.5%) | -$29.19 M(+19.0%) |
June 2024 | - | -$12.00 M(+61.0%) | -$24.53 M(+12.9%) |
Mar 2024 | - | -$7.46 M(+110.2%) | -$21.73 M(+13.8%) |
Dec 2023 | -$19.09 M(+23.9%) | -$3.55 M(+133.4%) | -$19.09 M(+1.3%) |
Sept 2023 | - | -$1.52 M(-83.5%) | -$18.84 M(+0.9%) |
June 2023 | - | -$9.21 M(+91.2%) | -$18.68 M(+25.0%) |
Mar 2023 | - | -$4.81 M(+46.1%) | -$14.94 M(-3.1%) |
Dec 2022 | -$15.41 M(-123.4%) | -$3.30 M(+142.4%) | -$15.41 M(+7.4%) |
Sept 2022 | - | -$1.36 M(-75.1%) | -$14.35 M(-16.0%) |
June 2022 | - | -$5.47 M(+3.5%) | -$17.09 M(-128.7%) |
Mar 2022 | - | -$5.28 M(+136.4%) | $59.46 M(-9.8%) |
Dec 2021 | $65.92 M(-195.7%) | -$2.23 M(-45.5%) | $65.92 M(+0.6%) |
Sept 2021 | - | -$4.10 M(-105.8%) | $65.55 M(-14.2%) |
June 2021 | - | $71.08 M(+5965.3%) | $76.44 M(-1250.8%) |
Mar 2021 | - | $1.17 M(-144.9%) | -$6.64 M(-90.4%) |
Dec 2020 | -$68.88 M(+272.8%) | -$2.61 M(-138.4%) | -$68.88 M(-1.6%) |
Sept 2020 | - | $6.79 M(-156.6%) | -$70.02 M(-14.6%) |
June 2020 | - | -$11.99 M(-80.4%) | -$81.95 M(+9.5%) |
Mar 2020 | - | -$61.06 M(+1527.5%) | -$74.85 M(+305.2%) |
Dec 2019 | -$18.47 M | -$3.75 M(-27.1%) | -$18.47 M(-6.9%) |
Sept 2019 | - | -$5.14 M(+5.1%) | -$19.85 M(+6.0%) |
June 2019 | - | -$4.89 M(+4.5%) | -$18.73 M(+5.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | -$4.68 M(-8.6%) | -$17.78 M(+6.7%) |
Dec 2018 | -$16.66 M(-52.5%) | -$5.12 M(+27.2%) | -$16.66 M(-10.4%) |
Sept 2018 | - | -$4.03 M(+2.0%) | -$18.60 M(-12.7%) |
June 2018 | - | -$3.95 M(+10.9%) | -$21.30 M(-18.4%) |
Mar 2018 | - | -$3.56 M(-49.6%) | -$26.10 M(-25.5%) |
Dec 2017 | -$35.05 M(-41.5%) | -$7.06 M(+5.0%) | -$35.05 M(-18.0%) |
Sept 2017 | - | -$6.73 M(-23.1%) | -$42.76 M(-21.1%) |
June 2017 | - | -$8.75 M(-30.1%) | -$54.22 M(-9.0%) |
Mar 2017 | - | -$12.52 M(-15.3%) | -$59.58 M(-0.6%) |
Dec 2016 | -$59.93 M(+37.1%) | -$14.77 M(-18.8%) | -$59.93 M(+0.6%) |
Sept 2016 | - | -$18.19 M(+28.9%) | -$59.60 M(+12.3%) |
June 2016 | - | -$14.11 M(+9.7%) | -$53.07 M(+7.3%) |
Mar 2016 | - | -$12.86 M(-10.9%) | -$49.46 M(+13.2%) |
Dec 2015 | -$43.70 M(+233.7%) | -$14.44 M(+23.9%) | -$43.70 M(+31.4%) |
Sept 2015 | - | -$11.65 M(+11.0%) | -$33.26 M(+31.1%) |
June 2015 | - | -$10.50 M(+47.9%) | -$25.36 M(+42.5%) |
Mar 2015 | - | -$7.10 M(+77.5%) | -$17.80 M(+35.9%) |
Dec 2014 | -$13.10 M(+46.1%) | -$4.00 M(+6.5%) | -$13.10 M(+44.0%) |
Sept 2014 | - | -$3.76 M(+27.8%) | -$9.10 M(+70.4%) |
June 2014 | - | -$2.94 M(+22.7%) | -$5.34 M(+122.7%) |
Mar 2014 | - | -$2.40 M | -$2.40 M |
Dec 2013 | -$8.97 M(-26.4%) | - | - |
Dec 2012 | -$12.18 M | - | - |
FAQ
- What is XBiotech annual free cash flow?
- What is the all time high annual FCF for XBiotech?
- What is XBiotech annual FCF year-on-year change?
- What is XBiotech quarterly free cash flow?
- What is the all time high quarterly FCF for XBiotech?
- What is XBiotech quarterly FCF year-on-year change?
- What is XBiotech TTM free cash flow?
- What is the all time high TTM FCF for XBiotech?
- What is XBiotech TTM FCF year-on-year change?
What is XBiotech annual free cash flow?
The current annual FCF of XBIT is -$19.09 M
What is the all time high annual FCF for XBiotech?
XBiotech all-time high annual free cash flow is $65.92 M
What is XBiotech annual FCF year-on-year change?
Over the past year, XBIT annual free cash flow has changed by -$3.68 M (-23.87%)
What is XBiotech quarterly free cash flow?
The current quarterly FCF of XBIT is -$6.18 M
What is the all time high quarterly FCF for XBiotech?
XBiotech all-time high quarterly free cash flow is $71.08 M
What is XBiotech quarterly FCF year-on-year change?
Over the past year, XBIT quarterly free cash flow has changed by -$4.66 M (-306.78%)
What is XBiotech TTM free cash flow?
The current TTM FCF of XBIT is -$29.19 M
What is the all time high TTM FCF for XBiotech?
XBiotech all-time high TTM free cash flow is $76.44 M
What is XBiotech TTM FCF year-on-year change?
Over the past year, XBIT TTM free cash flow has changed by -$10.36 M (-54.98%)